This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-3884v1 69/10/4502    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Szeto, M. D. Articles by Swanson, K. R. Search for Related Content PubMed PubMed Citation Articles by Szeto, M. D. Articles by Swanson, K. R.

Quantitative Metrics of Net Proliferation and Invasion Link Biological Aggressiveness Assessed by MRI with Hypoxia Assessed by FMISO-PET in Newly Diagnosed Glioblastomas

Departments of ¹ Pathology, ² Radiology, and ³ Neurology, University of Washington School of Medicine, Seattle, Washington

Requests for reprints: Kristin R. Swanson, Laboratory of Neuropathology, University of Washington, 325 9th Avenue, Box 359791, Seattle, WA 98104. Phone: 206-221-6577; Fax: 206-685-7271; E-mail: swanson{at}amath.washington.edu.

Key Words: glioblastoma • MRI • FMISO-PET • biomathematical model • hypoxia

Glioblastoma multiforme (GBM) are aggressive and uniformly fatal primary brain tumors characterized by their diffuse invasion of the normal-appearing parenchyma peripheral to the clinical imaging abnormality. Hypoxia, a hallmark of aggressive tumor behavior often noted in GBMs, has been associated with resistance to therapy, poorer survival, and more malignant tumor phenotypes. Based on the existence of a set of novel imaging techniques and modeling tools, our objective was to assess a hypothesized quantitative link between tumor growth kinetics [assessed via mathematical models and routine magnetic resonance imaging (MRI)] and the hypoxic burden of the tumor [assessed via positron emission tomography (PET) imaging]. Our biomathematical model for glioma kinetics describes the spatial and temporal evolution of a glioma in terms of concentration of malignant tumor cells. This model has already been proven useful as a novel tool to dynamically quantify the net rates of proliferation () and invasion (D) of the glioma cells in individual patients. Estimates of these kinetic rates can be calculated from routinely available pretreatment MRI in vivo. Eleven adults with GBM were imaged preoperatively with ¹⁸F-fluoromisonidazole (FMISO)–PET and serial gadolinium-enhanced T1- and T2-weighted MRIs to allow the estimation of patient-specific net rates of proliferation () and invasion (D). Hypoxic volumes were quantified from each FMISO-PET scan following standard techniques. To control for tumor size variability, two measures of hypoxic burden were considered: relative hypoxia (RH), defined as the ratio of the hypoxic volume to the T2-defined tumor volume, and the mean intensity on FMISO-PET scaled to the blood activity of the tracer (mean T/B). Pearson correlations between RH and the net rate of cell proliferation () reached significance (P < 0.04). Moreover, highly significant positive correlations were found between biological aggressiveness ratio (/D) and both RH (P < 0.00003) and the mean T/B (P < 0.0007). [Cancer Res 2009;69(10):4502–9]

Major Findings: Overall, biological aggressiveness assessed by serial MRI is linked with hypoxic burden assessed on FMISO-PET using a novel biomathematical model for glioma growth and invasion. This study suggests that patient-specific modeling of growth kinetics can provide novel and valuable insight into the quantitative connections between disparate information provided by multimodality imaging.